ASMI
ASMI warns consumers against buying CMs from overseas
ASMI says consumers should only purchase complementary medicines approved for supply in Australia because they are highly regulated by the TGA. “Australia’s system of regulating complementary medicines is one of …
Support investment and innovation in OTCs: ASMI
In its 2016 pre-Budget Submission, ASMI has proposed three regulatory reforms to incentivise investment and innovation in the non-prescription medicines sector and increase consumer access to medicines. “The non-prescription medicines …
ASMI arguing for continued pharmacy codeine access
In its submission to the supplementary consultation on the scheduling of OTC codeine medicines, ASMI supported regulatory options that reduce the risk of codeine misuse, while retaining pharmacy access for …
ASMI supports voluntary country of origin labelling
In its submission to the consultation on the Regulation Impact Statement for country of origin labelling, ASMI says it advocated for voluntary country of origin labelling for therapeutic goods. “ASMI …
Minor Ailments Scheme evidence-based, efficient: stakeholders
A Minor Ailments Scheme similar to that in the UK or Canada would be an evidence-based program aimed at improving the health of Australians, industry stakeholders say. On Monday prominent …
Minor Ailments Scheme just a drug sales push: GP
The proposed Minor Ailments Scheme based in pharmacy is just “a push by the pharmaceutical industry and pharmacy business to increase drug sales under the guise of health innovation,” according …
ASMI welcomes further consultation on codeine
The Australian Self Medication Industry has today welcomed the announcement by the TGA of a further consultation regarding scheduling of OTC codeine medicines. “The TGA’s proposed amendments take a more …
Stakeholders welcome regulatory framework report
The Australian Self Medication Industry and Complementary Medicines Australia have welcomed the Stage Two Expert Panel report on the regulatory framework for medicines and medical devices. “ASMI supports the majority …
Stakeholders gear up on real-time codeine monitoring
The deferment of a final decision on the upscheduling of codeine-containing OTCs is very good news, but stakeholders now need to get moving quickly on the proposed real-time monitoring system …
ASMI welcomes UK Self Care Week
The Australian Self Medication Industry has welcomed the UK’s Self Care Week, which puts the spotlight on ways people can take better care of their own health in partnership with …
ASMI celebrates excellence in quality use of medicines
Excellence in quality use of medicines was celebrated at a Australian Self Medication Industry gala awards dinner in Sydney last night. The recipients of a QUM marketing award and two …
Momentum building for switch environment, S3 advertising policy: ASMI
Momentum is building for reform of the switch environment and Schedule 3 advertising policy, said presenters and participants at ASMI’s annual conference yesterday. ASMI Chief Executive Officer, Deon Schoombie, said: …